|
No. of patients with P. mirabilis = 20
| | | | | | | |
|---|
|
Drug groups
|
Active substance
|
No. using antibiotics (%)
|
No. of tests of antibiotics on antibiogram (%)
|
Sensitive (%)
|
Intermediate (%)
|
Resistant (%)
|
P value compared to ampicillin
|
|---|
|
Penicillins
|
Ampicillin
|
0
|
20 (100)
|
8 (40.0)
|
1 (5.0)
|
11 (55.0)
| |
| |
Piperacillin
|
1 (5.0)
|
20 (100)
|
13 (65.0)
|
4 (20.0)
|
3 (15.0)
|
0.023
|
|
Penicillin + Beta-lactamase inhibitors
|
Ampicillin + Sulbactam
|
3 (15.0)
|
20 (100)
|
13 (65.0)
|
3 (15.0)
|
4 (20.0)
|
0.065
|
| |
Piperacillin + Tazobactam
|
15 (75.0)
|
20 (100)
|
20 (100)
|
0
|
0
|
0.0002
|
|
Cephalosporins
|
Cefepime
|
0
|
19 (95.0)
|
19 (100)
|
0
|
0
|
0.0003
|
| |
Cefotaxime
|
0
|
20 (100)
|
18 (90.0)
|
0
|
2 (10.0)
|
0.004
|
| |
Ceftazidime
|
1 (5.0)
|
16 (80.0)
|
16 (100)
|
0
|
0
|
0.0007
|
| |
Cefuroxime
|
0
|
20 (100)
|
15 (75.0)
|
0
|
5 (25.0)
|
0.068
|
|
Glycylcycline
|
Tetracycline
|
0
|
13 (65.0)
|
0
|
0
|
13 (100)
|
0.018
|
| |
Tigecycline
|
0
|
1 (5.0)
|
1 (100)
|
0
|
0
|
0.497
|
|
Carbapenems
|
Imipenem
|
3 (15.0)
|
20 (100)
|
19 (95.0)
|
1(5.0)
|
0
|
0.0004
|
| |
Meropenem
|
0
|
19 (95.0)
|
18 (94.7)
|
1 (5.3)
|
0
|
0.0006
|
|
Gyrase inhibitors
|
Ciprofloxacin
|
1 (5.0)
|
18 (90.0)
|
15 (83.3)
|
1 (5.6)
|
2 (13.3)
|
0.016
|
| |
Levofloxacin
|
1 (5.0)
|
14 (70.0)
|
13 (92.9)
|
1 (7.1)
|
0
|
0.003
|
|
Aminoglycoside
|
Amikacin
|
0
|
9 (45.0)
|
9 (100)
|
0
|
0
|
0.01
|
| |
Gentamicin
|
2 (10.0)
|
19 (95.0)
|
16 (84.2)
|
0
|
3 (15.8)
|
0.080
|
| |
Tobramycin
|
0
|
11 (55.0)
|
8 (72.7)
|
1 (9.1)
|
2 (18.2)
|
0.139
|
|
Trimethoprim + Sulfamethoxazole
|
Co-trimoxazole
|
0
|
20 (100)
|
14 (70.0)
|
0
|
6 (30.0)
|
0.321
|
|
Others
|
Fosfomycin
|
0
|
5 (25.0)
|
5 (100)
|
0
|
0
|
0.056
|
- Note: Significant P values shown in bold
